BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 14732921)

  • 21. Clonal evolution in t(14;18)-positive follicular lymphoma, evidence for multiple common pathways, and frequent parallel clonal evolution.
    d'Amore F; Chan E; Iqbal J; Geng H; Young K; Xiao L; Hess MM; Sanger WG; Smith L; Wiuf C; Hagberg O; Fu K; Chan WC; Dave BJ
    Clin Cancer Res; 2008 Nov; 14(22):7180-7. PubMed ID: 19010834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of secondary chromosomal alterations in 165 cases of follicular lymphoma with t(14;18).
    Horsman DE; Connors JM; Pantzar T; Gascoyne RD
    Genes Chromosomes Cancer; 2001 Apr; 30(4):375-82. PubMed ID: 11241790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular cytogenetic analysis of follicular lymphoma (FL) provides detailed characterization of chromosomal instability associated with the t(14;18)(q32;q21) positive and negative subsets and histologic progression.
    Nanjangud G; Rao PH; Teruya-Feldstein J; Donnelly G; Qin J; Mehra S; Jhanwar SC; Zelenetz AD; Chaganti RS
    Cytogenet Genome Res; 2007; 118(2-4):337-44. PubMed ID: 18000388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uncovering novel inter- and intrachromosomal chromosome 1 aberrations in follicular lymphomas by using an innovative multicolor banding technique.
    Lestou VS; Gascoyne RD; Salski C; Connors JM; Horsman DE
    Genes Chromosomes Cancer; 2002 Jun; 34(2):201-10. PubMed ID: 11979554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A marginal zone phenotype in follicular lymphoma with t(14;18) is associated with secondary cytogenetic aberrations typical of marginal zone lymphoma.
    Torlakovic EE; Aamot HV; Heim S
    J Pathol; 2006 Jun; 209(2):258-64. PubMed ID: 16583359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of cytogenetic subgroups and karyotypic pathways of clonal evolution in follicular lymphomas.
    Höglund M; Sehn L; Connors JM; Gascoyne RD; Siebert R; Säll T; Mitelman F; Horsman DE
    Genes Chromosomes Cancer; 2004 Mar; 39(3):195-204. PubMed ID: 14732921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Analysis of genomic copy number alterations of malignant lymphomas and its application for diagnosis].
    Tagawa H
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):975-82. PubMed ID: 17637530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytogenetic mechanisms in the pathogenesis and progression of follicular lymphoma.
    Knutsen T
    Cancer Surv; 1997; 30():163-92. PubMed ID: 9547992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytogenetic analysis of tumor clonality.
    Teixeira MR; Heim S
    Adv Cancer Res; 2011; 112():127-49. PubMed ID: 21925303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The patterns of the karyotypic evolution of cells in culture].
    Mamaeva SE
    Tsitologiia; 1996; 38(8):787-814. PubMed ID: 9027012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast cancer cytogenetics: a review and proposal for clinical application.
    Cervantes M; Glassman AB
    Ann Clin Lab Sci; 1996; 26(3):208-14. PubMed ID: 8726213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acquired chromosomal rearrangements targeting selected transcription factors: contribution of molecular cytogenetic and expression analyses to the identification of clinically and biologically relevant subgroups in hematological malignancies.
    Poppe B; De Paepe A; Speleman F
    Verh K Acad Geneeskd Belg; 2007; 69(1):47-64. PubMed ID: 17427874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytogenetic evolution of follicular lymphoma.
    Viardot Aa; Barth TF; Möller P; Döhner H; Bentz M
    Semin Cancer Biol; 2003 Jun; 13(3):183-90. PubMed ID: 12959349
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.